632 related articles for article (PubMed ID: 19644870)
1. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation.
Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T
Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870
[TBL] [Abstract][Full Text] [Related]
2. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
[TBL] [Abstract][Full Text] [Related]
3. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of anti-phosphatidylserine-prothrombin complex antibodies in antiphospholipid syndrome].
Kaburaki J; Kuwana M; Kameda H; Takeuchi T; Okada J; Katayama M; Yoshida S; Ikeda Y
Rinsho Ketsueki; 2005 Jan; 46(1):19-21. PubMed ID: 16708913
[TBL] [Abstract][Full Text] [Related]
5. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
Hanly JG; Smith SA
J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
[TBL] [Abstract][Full Text] [Related]
6. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T
Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome?
Jaskowski TD; Wilson AR; Hill HR; Branch WD; Tebo AE
Clin Chim Acta; 2009 Dec; 410(1-2):19-24. PubMed ID: 19751711
[TBL] [Abstract][Full Text] [Related]
8. Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody.
Oku K; Amengual O; Zigon P; Horita T; Yasuda S; Atsumi T
Rheumatology (Oxford); 2013 Oct; 52(10):1775-84. PubMed ID: 23878313
[TBL] [Abstract][Full Text] [Related]
9. Antiprothrombin antibody testing: detection and clinical utility.
Oku K; Atsumi T; Amengual O; Koike T
Semin Thromb Hemost; 2008 Jun; 34(4):335-9. PubMed ID: 18814066
[TBL] [Abstract][Full Text] [Related]
10. Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Rheumatology (Oxford); 2009 May; 48(5):508-12. PubMed ID: 19273539
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to phosphatidylserine/prothrombin complex as an additional diagnostic marker of APS?
Žigon P; Čučnik S; Ambrožič A; Sodin Šemrl S; Kveder T; Božič B
Lupus; 2012 Jun; 21(7):790-2. PubMed ID: 22635235
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of anti-phosphatidylserine-prothrombin complex antibodies in the diagnosis of anti-phospholipid syndrome].
Kaburaki J; Kuwana M; Ikeda Y
Rinsho Ketsueki; 2003 Jan; 44(1):28-30. PubMed ID: 12649835
[TBL] [Abstract][Full Text] [Related]
13. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
14. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y
Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
[TBL] [Abstract][Full Text] [Related]
15. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
16. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis.
Hasegawa M; Sato S; Yanaba K; Komura K; Yamazaki M; Takehara K
Ann Rheum Dis; 2004 Nov; 63(11):1514-7. PubMed ID: 15479907
[TBL] [Abstract][Full Text] [Related]
18. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome.
Vlagea A; Gil A; Cuesta MV; Arribas F; Diez J; Lavilla P; Pascual-Salcedo D
Clin Appl Thromb Hemost; 2013 Jun; 19(3):289-96. PubMed ID: 22387581
[TBL] [Abstract][Full Text] [Related]
19. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
[TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibodies against the complex of phosphatidylserine and prothrombin from patients with the antiphospholipid antibodies.
Horita T; Ichikawa K; Kataoka H; Yasuda S; Atsumi T; Koike T
Lupus; 2007; 16(7):509-16. PubMed ID: 17670850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
